✦ LIBER ✦

PMS42 COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM

✍ Scribed by O Purcaru; PC Taylor; P Emery; S Palmer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS45 Cost-Utility and Budget Impact Ana

✍ N. Maniadakis; D. Boumpas; G. Kourlaba; P. Christou; I. Anargiros; E. Smets; O P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PMS37 THE COST-EFFECTIVENESS OF ABATACEP

✍ M Lebmeier; L Pericleous; P Drost; P Dequen; M Ouwens; G Bergman; H Baig 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMS46 Cost-Utility Analysis of Certolizu

✍ R. Villoro; A. Hidalgo; B. Ferro; P. Talavera 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PMS31 Cost-Effectiveness of Abatacept fo

✍ L. Pericleous; M. Lebmeier 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

BL1 COST-EFFECTIVENESS, VALUE OF INFORMA

✍ EJ Soini; T Hallinen; M Taiha; V Honkanen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PMS35 Cost-Effectiveness of Tocilizumab

✍ I. Ertenli 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB